273 related articles for article (PubMed ID: 10698518)
1. Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer.
Newman SP; Bates NP; Vernimmen D; Parker MG; Hurst HC
Oncogene; 2000 Jan; 19(4):490-7. PubMed ID: 10698518
[TBL] [Abstract][Full Text] [Related]
2. AP-2 transcription factors in the regulation of ERBB2 gene transcription by oestrogen.
Perissi V; Menini N; Cottone E; Capello D; Sacco M; Montaldo F; De Bortoli M
Oncogene; 2000 Jan; 19(2):280-8. PubMed ID: 10645007
[TBL] [Abstract][Full Text] [Related]
3. An intron 1 enhancer element mediates oestrogen-induced suppression of ERBB2 expression.
Bates NP; Hurst HC
Oncogene; 1997 Jul; 15(4):473-81. PubMed ID: 9242384
[TBL] [Abstract][Full Text] [Related]
4. Activator protein-2gamma (AP-2gamma) expression is specifically induced by oestrogens through binding of the oestrogen receptor to a canonical element within the 5'-untranslated region.
Orso F; Cottone E; Hasleton MD; Ibbitt JC; Sismondi P; Hurst HC; De Bortoli M
Biochem J; 2004 Jan; 377(Pt 2):429-38. PubMed ID: 14565844
[TBL] [Abstract][Full Text] [Related]
5. Identification of HTF (HER2 transcription factor) as an AP-2 (activator protein-2) transcription factor and contribution of the HTF binding site to ERBB2 gene overexpression.
Vernimmen D; Begon D; Salvador C; Gofflot S; Grooteclaes M; Winkler R
Biochem J; 2003 Feb; 370(Pt 1):323-9. PubMed ID: 12418962
[TBL] [Abstract][Full Text] [Related]
6. A negative feedback regulatory loop associates the tyrosine kinase receptor ERBB2 and the transcription factor GATA4 in breast cancer cells.
Hua G; Zhu B; Rosa F; Deblon N; Adélaïde J; Kahn-Perlès B; Birnbaum D; Imbert J
Mol Cancer Res; 2009 Mar; 7(3):402-14. PubMed ID: 19276186
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional control of the ERBB2 amplicon by ERRalpha and PGC-1beta promotes mammary gland tumorigenesis.
Deblois G; Chahrour G; Perry MC; Sylvain-Drolet G; Muller WJ; Giguère V
Cancer Res; 2010 Dec; 70(24):10277-87. PubMed ID: 20961995
[TBL] [Abstract][Full Text] [Related]
8. Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways.
Turner BC; Zhang J; Gumbs AA; Maher MG; Kaplan L; Carter D; Glazer PM; Hurst HC; Haffty BG; Williams T
Cancer Res; 1998 Dec; 58(23):5466-72. PubMed ID: 9850080
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen-induced ER-alpha-SRC-3 interaction in HER2 positive human breast cancer; a possible mechanism for ER isoform specific recurrence.
Mc Ilroy M; Fleming FJ; Buggy Y; Hill AD; Young LS
Endocr Relat Cancer; 2006 Dec; 13(4):1135-45. PubMed ID: 17158759
[TBL] [Abstract][Full Text] [Related]
10. FGFR4 overexpression in pancreatic cancer is mediated by an intronic enhancer activated by HNF1alpha.
Shah RN; Ibbitt JC; Alitalo K; Hurst HC
Oncogene; 2002 Nov; 21(54):8251-61. PubMed ID: 12447688
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptors: selective ligands, partners, and distinctive pharmacology.
Katzenellenbogen BS; Montano MM; Ediger TR; Sun J; Ekena K; Lazennec G; Martini PG; McInerney EM; Delage-Mourroux R; Weis K; Katzenellenbogen JA
Recent Prog Horm Res; 2000; 55():163-93; discussion 194-5. PubMed ID: 11036937
[TBL] [Abstract][Full Text] [Related]
12. [Relationship of oncogene C-erbB2 expression to ER, PR and PS2 in breast cancer and its prognostic significance].
Yang JQ; Chen L; Xing TY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):334-6, 357. PubMed ID: 15181828
[TBL] [Abstract][Full Text] [Related]
13. pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.
Macaluso M; Cinti C; Russo G; Russo A; Giordano A
Oncogene; 2003 Jun; 22(23):3511-7. PubMed ID: 12789259
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional activation of the oxytocin promoter by oestrogens uses a novel non-classical mechanism of oestrogen receptor action.
Koohi MK; Ivell R; Walther N
J Neuroendocrinol; 2005 Apr; 17(4):197-207. PubMed ID: 15842231
[TBL] [Abstract][Full Text] [Related]
15. Modulation of oestrogen receptor signalling by association with the activated dioxin receptor.
Ohtake F; Takeyama K; Matsumoto T; Kitagawa H; Yamamoto Y; Nohara K; Tohyama C; Krust A; Mimura J; Chambon P; Yanagisawa J; Fujii-Kuriyama Y; Kato S
Nature; 2003 May; 423(6939):545-50. PubMed ID: 12774124
[TBL] [Abstract][Full Text] [Related]
16. Expression of the human oestrogen receptor-alpha gene is regulated by promoter F in MG-63 osteoblastic cells.
Lambertini E; Penolazzi L; Giordano S; Del Senno L; Piva R
Biochem J; 2003 Jun; 372(Pt 3):831-9. PubMed ID: 12659635
[TBL] [Abstract][Full Text] [Related]
17. Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor.
Hyder SM; Nawaz Z; Chiappetta C; Stancel GM
Cancer Res; 2000 Jun; 60(12):3183-90. PubMed ID: 10866309
[TBL] [Abstract][Full Text] [Related]
18. Interaction of oestrogen and peroxisome proliferator-activated receptors with apolipoprotein(a) gene enhancers.
Puckey LH; Knight BL
Biochem J; 2002 Aug; 366(Pt 1):157-63. PubMed ID: 12023905
[TBL] [Abstract][Full Text] [Related]
19. Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen.
Hurtado A; Holmes KA; Geistlinger TR; Hutcheson IR; Nicholson RI; Brown M; Jiang J; Howat WJ; Ali S; Carroll JS
Nature; 2008 Dec; 456(7222):663-6. PubMed ID: 19005469
[TBL] [Abstract][Full Text] [Related]
20. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF
Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
